These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6486734)

  • 1. Epifocal dinitrochlorobenzene therapy in malignant melanoma (experience during the last eight years).
    Illig L; Paul E; Bödeker RH
    Anticancer Res; 1984; 4(4-5):293-8. PubMed ID: 6486734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The nonspecific epifocal Malek-Mansour immunotherapy of malignant cutaneous melanoma using DNCB].
    Illig L; Paul E
    Hautarzt; 1976 Dec; 27(12):579-87. PubMed ID: 1010745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of malignant melanoma with dinitrochlorobenzene ointment].
    Loth H; Ehring F
    Hautarzt; 1978 Mar; 29(3):141-6. PubMed ID: 640834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adjuvant DNCB immunotherapy in malignant melanoma].
    Weidner F; Djawari D
    Z Hautkr; 1979 May; 54(10):436-43. PubMed ID: 473840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contribution to treatment of malignant melanoblastoma by the local application of DNCB (author's transl)].
    Duchková H; Richter J; Kubíková M
    Cesk Dermatol; 1978 Jun; 53(3):169-72. PubMed ID: 679282
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosurgical approach to the treatment of malignant melanoma using 2,4-dinitrochlorobenzene (DNCB).
    Lukács L; István M
    Neoplasma; 1984; 31(4):437-45. PubMed ID: 6472514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [1-Chloro-2,4-dinitrobenzene ointment for sensitization, testing and therapy of malignant melanoma patients].
    Burg G; Braun-Falco O
    Dtsch Med Wochenschr; 1977 Feb; 102(6):210-1. PubMed ID: 832608
    [No Abstract]   [Full Text] [Related]  

  • 8. [Survival analysis in patients with cutaneous malignant melanoma].
    Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
    Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiotherapy of malignant melanoma of the skin].
    Suter L; Fuhrmann D
    Praxis (Bern 1994); 2001 Mar; 90(10):397-402. PubMed ID: 11305185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunochemotherapy of malignant melanoma. Epifocal administration of dinitrochlorobenzene (DNCB) combined with systemic chemotherapy with dacarbazine (DTIC)].
    Trcka J; Kämpgen E; Becker JC; Schwaaf A; Bröcker EB
    Hautarzt; 1998 Jan; 49(1):17-22. PubMed ID: 9522188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological behavior and natural course of acral malignant melanoma. Clinical and histologic features and prognosis of palmoplantar, subungual, and other acral malignant melanomas.
    Jimbow K; Takahashi H; Miura S; Ikeda S; Kukita A
    Am J Dermatopathol; 1984; 6 Suppl():43-53. PubMed ID: 6528942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
    McKenna DB; Lee RJ; Prescott RJ; Doherty VR
    Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [DNCB immunotherapy for removal of melanoma skin metastases].
    Wätzig V
    Dermatol Monatsschr; 1977 Oct; 163(10):848-50. PubMed ID: 923876
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of epithelioms with DNCB].
    Romaguera Sagrera C; Castel R; Pedragosa R; Piñol Aguade J
    Med Cutan Ibero Lat Am; 1974; 2(6):471-6. PubMed ID: 4478914
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cross allergies following sensitization with dinitrochlorbenzol (DNCB)].
    Djawari D; Körner E; Haneke E
    Hautarzt; 1980 Apr; 31(4):198-202. PubMed ID: 7399912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical management of orbital malignant melanoma: our experience and a report of three cases].
    Poli T; Mora P; Reichegger V; Ricci R; Corradi D; Gandolfi SA; Sesenna E
    Klin Monbl Augenheilkd; 2007 Oct; 224(10):794-8. PubMed ID: 17952825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit.
    McKinnon JG; Yu XQ; McCarthy WH; Thompson JF
    Cancer; 2003 Sep; 98(6):1223-31. PubMed ID: 12973846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced survival in patients with multiple primary melanoma.
    Doubrovsky A; Menzies SW
    Arch Dermatol; 2003 Aug; 139(8):1013-8. PubMed ID: 12925389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives.
    Durando X; Thivat E; D'Incan M; Sinsard A; Madelmont JC; Chollet P
    BMC Cancer; 2005 Nov; 5():147. PubMed ID: 16287507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Melanoma in organ transplant patients].
    Lévêque L; Dalac S; Dompmartin A; Louvet S; Euvrard S; Catteau B; Hazan M; Schollhamer M; Aubin F; Dreno B; Daguin P; Chevrant-Breton J; Frances C; Bismuth MJ; Tanter Y; Lambert D
    Ann Dermatol Venereol; 2000 Feb; 127(2):160-5. PubMed ID: 10739973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.